Discovery of Glu2Py: a water-soluble glycosylated MAP4K4 inhibitor for targeted ischemia–reperfusion therapy
Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4/HGK) is a validated upstream activator of the JNK/p38 stress-signaling axis implicated in cardiac ischemia–reperfusion injury (IRI), inflammatory disease, and cancer. Despite its therapeutic relevance, no MAP4K4 inhibitor has advanced to clinical use, part...